Glycochenodeoxycholic Acid (sodium salt hydrate)

Formulation: A crystalline solid

Formal Name: N-[(3α,5β,7α)-3,7-dihydroxy-24-oxocholan-24-yl]-glycine, monosodium salt, hydrate

Purity: ≥95%

Formula Markup: C26H42NO5 • Na [XH2O]

Formula Weight: 471,6

Shelf life (days): 1460

Notes: Glycochenodeoxycholic acid (GCDCA) is a glycine-conjugated form of the primary bile acid chenodeoxycholic acid (Item No. 10011286).{57144} It reduces formation of cholic acid (Item No. 20250) in primary human hepatocytes when used at a concentration of 100 µM.{57145} GCDCA (50, 75, and 100 µM) reduces the number of LC3 puncta, a marker of autophagy, and is cytotoxic to L-02 hepatocytes.{57144} GCDCA (50 µM) induces apoptosis in isolated rat hepatocytes, an effect that can be blocked by the protein kinase C (PKC) inhibitor chelerythrine (Item No. 11314).{57146} Fecal levels of GCDCA are decreased in a rat model of high-fat diet-induced obesity compared with rats fed a normal diet.{54007}

• Artikelnummer: CAY16942-100
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 16942-100
• Green Labware: Nein
• Verpackungseinheit: 100 mg
• Mengeneinheit: STK